Supplemental Patch Testing Identifies Allergens Missed by Standard Screening Series
Dermatitis® · 01.07.2024 · 35 (4) · 366-372
DOI: 10.1089/derm.2023.0310 ↗Kurz gefasst
Fachartikel in der Zeitschrift Dermatitis®, online erschienen am 24.07.2024. Verfasst von Amber Reck Atwater und 5 weiteren Autor:innen. Beteiligte Einrichtung: From the Departments of Dermatology, Duke University Medical Center, Durham, North Carolina, USA. Hauptthemen laut MEDLINE: Patch Tests, Dermatitis, Allergic Contact, Allergens. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 11 Literaturangaben.
Abstract (Originalsprache)
Background
Supplemental patch testing is an adjunct to standard patch test screening series.
Objective
To determine the demographics, characteristics, frequency, relevance, and interpretation of patch test reactions for supplemental patch testing.
Methods
Retrospective study of patients tested 2017–2020 with North American Contact Dermatitis Group (NACDG) and supplemental screening series (Supplemental Series A [SSA], Supplemental Series B [SSB]). Demographics, characteristics, reaction strengths, relevance, and final interpretation were recorded.
Results
Cohort included 791 patients; 73.5% female, 68.6% age >40 years. 74.1% were White, 15.2% Black, 5.7% Asian, and 1.5% Hispanic. The most common Dermatitis sites were scattered/generalized (27.2%), face (24.0%), and hands (23.5%). For 2017–2018 and 2019–2020, respectively, 82% (318/388) and 78.4% (316/403) had ≥1 “allergic” reaction. In addition, 13.5% (52/385) and 11.7% (47/403) had SSA reactions, and 38.1% (115/302) and 31.5% (101/321) had SSB reactions. In the 87 (2017–2018) and 99 (2019–2020) patients with negative NACDG testing, 17 (19.5%) and 12 (12.1%) had supplemental reactions. Of the 34 supplemental allergens with reaction frequency ≥1%, 58.8% (20/34) are not part of the American Contact Dermatitis Society 90 (2020) or NACDG 2021–2022 screening series. The highest frequency allergens from this group were dodecyl and octyl gallate, cinnamic alcohol, phenyl salicylate, hexahydro-1,3,5-tris-(2-hydroxyethyl) triazine, and abitol.
Conclusions
Supplemental patch testing identifies additional relevant allergens in patients with suspected allergic contact Dermatitis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From the Departments of Dermatology, Duke University Medical Center, Durham, North Carolina, USA.
- Biostatistics and Bioinformatics, Duke University Medical Center, Durham, North Carolina, USA.
ORCID-Profile: Amber Reck Atwater
Zitieren
APA
Atwater, A. R., Liu, B., Walsh, R., Bembry, R., Ward, J. M., & Green, C. L. (2024). Supplemental Patch Testing Identifies Allergens Missed by Standard Screening Series. Dermatitis®, 35(4), 366-372. https://doi.org/10.1089/derm.2023.0310
Vancouver
Atwater AR, Liu B, Walsh R, Bembry R, Ward JM, Green CL. Supplemental Patch Testing Identifies Allergens Missed by Standard Screening Series. Dermatitis®. 2024;35(4):366-372. doi:10.1089/derm.2023.0310
BibTeX
@article{Atwater2024,
author = {Atwater, Amber Reck and Liu, Beiyu and Walsh, Rabina and Bembry, Raina and Ward, Jordan Maxwell and Green, Cynthia L},
title = {Supplemental Patch Testing Identifies Allergens Missed by Standard Screening Series},
journal = {Dermatitis®},
year = {2024},
volume = {35},
number = {4},
pages = {366--372},
doi = {10.1089/derm.2023.0310}
}
EUVIMED